Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
FDA Orange Book EMA EPAR documents ClinicalTrials.gov SEC filings (Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca) Proprietary Elements CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 10 years
MiR-27a inhibits the expression of several lipid metabolic genes, including SREBP1-2, FASN, and PPAR/, by reducing lipid synthesis and increasing lipid secretion from cells 92
The degradation of intracellular fat, sugar, long-lived proteins, and proteins that are misfolded or precipitated due to a disease-related mutation depends on autophagy
Cai X, She M, Xu M, Chen H, Li J, Chen X, Zheng D, Liu J, Chen S, Zhu J
US$ 29.45
US$ 22.46
US$ 23.56
US$ 28.92
US$ 25.18
US$ 24.50
US$ 23.97
US$ 22.16
US$ 21.23
